Corrigendum to: LTBK-01. Updates On The Phase Ii And Re-treatment Study Of AZD6244 (Selumetinib) For Children With Recurrent Or Refractory Pediatric Low Grade Glioma: A Pediatric Brain Tumor Consortium (PBTC) Study. Academic Article

Overview

authors

Fangusaro, Jason R

Onar-Thomas, Arzu

Poussaint, Tina Young

Lindeman, Neal
Banerjee, Anuradha
Packer, Roger
Kilburn, Lindsay B
Pollack, Ian F
Qaddoumi, Ibrahim A
Fisher, Paul Graham
Dhall, Girish
Baxter, Patricia Ann
Kreissman, Susan G
Doyle, L Austin
Smith, Malcolm A
Fouladi, Maryam
Dunkel, Ira J

publication date

August 1, 2022

published in

Neuro-oncology Journal

Identity

PubMed Central ID

PMC9340620

Scopus Document Identifier

85135421512

Digital Object Identifier (DOI)

10.1093/neuonc/noac029

PubMed ID

35307742

Additional Document Info

volume

24

issue

8